240 related articles for article (PubMed ID: 8652841)
1. BCL-6 expression during B-cell activation.
Allman D; Jain A; Dent A; Maile RR; Selvaggi T; Kehry MR; Staudt LM
Blood; 1996 Jun; 87(12):5257-68. PubMed ID: 8652841
[TBL] [Abstract][Full Text] [Related]
2. Distinctive expression pattern of the BCL-6 protein in nodular lymphocyte predominance Hodgkin's disease.
Falini B; Bigerna B; Pasqualucci L; Fizzotti M; Martelli MF; Pileri S; Pinto A; Carbone A; Venturi S; Pacini R; Cattoretti G; Pescarmona E; Lo Coco F; Pelicci PG; Anagnastopoulos I; Dalla-Favera R; Flenghi L
Blood; 1996 Jan; 87(2):465-71. PubMed ID: 8555467
[TBL] [Abstract][Full Text] [Related]
3. BCL-6 gene product, a 92- to 98-kD nuclear phosphoprotein, is highly expressed in germinal center B cells and their neoplastic counterparts.
Onizuka T; Moriyama M; Yamochi T; Kuroda T; Kazama A; Kanazawa N; Sato K; Kato T; Ota H; Mori S
Blood; 1995 Jul; 86(1):28-37. PubMed ID: 7795234
[TBL] [Abstract][Full Text] [Related]
4. Expression status of BCL-6 and syndecan-1 identifies distinct histogenetic subtypes of Hodgkin's disease.
Carbone A; Gloghini A; Gaidano G; Franceschi S; Capello D; Drexler HG; Falini B; Dalla-Favera R
Blood; 1998 Oct; 92(7):2220-8. PubMed ID: 9746758
[TBL] [Abstract][Full Text] [Related]
5. BCL-6 protein is expressed in germinal-center B cells.
Cattoretti G; Chang CC; Cechova K; Zhang J; Ye BH; Falini B; Louie DC; Offit K; Chaganti RS; Dalla-Favera R
Blood; 1995 Jul; 86(1):45-53. PubMed ID: 7795255
[TBL] [Abstract][Full Text] [Related]
6. Bcl-6 protein expression in normal and neoplastic lymphoid tissues.
Falini B; Fizzotti M; Pileri S; Liso A; Pasqualucci L; Flenghi L
Ann Oncol; 1997; 8 Suppl 2():101-4. PubMed ID: 9209651
[TBL] [Abstract][Full Text] [Related]
7. Expression of A-myb, but not c-myb and B-myb, is restricted to Burkitt's lymphoma, sIg+ B-acute lymphoblastic leukemia, and a subset of chronic lymphocytic leukemias.
Golay J; Luppi M; Songia S; Palvarini C; Lombardi L; Aiello A; Delia D; Lam K; Crawford DH; Biondi A; Barbui T; Rambaldi A; Introna M
Blood; 1996 Mar; 87(5):1900-11. PubMed ID: 8634438
[TBL] [Abstract][Full Text] [Related]
8. B cell receptor engagement and T cell contact induce Bcl-6 somatic hypermutation in human B cells: identity with Ig hypermutation.
Zan H; Li Z; Yamaji K; Dramitinos P; Cerutti A; Casali P
J Immunol; 2000 Jul; 165(2):830-9. PubMed ID: 10878357
[TBL] [Abstract][Full Text] [Related]
9. T-cell/histiocyte-rich large B-cell lymphoma: a heterogeneous entity with derivation from germinal center B cells.
Lim MS; Beaty M; Sorbara L; Cheng RZ; Pittaluga S; Raffeld M; Jaffe ES
Am J Surg Pathol; 2002 Nov; 26(11):1458-66. PubMed ID: 12409722
[TBL] [Abstract][Full Text] [Related]
10. BCL-6 in diffuse large-cell lymphomas.
Dalla-Favera R; Ye BH; Cattoretti G; Lo Coco F; Chang CC; Zhang J; Migliazza A; Cechova K; Niu H; Chaganti S; Chen W; Louie DC; Offit K; Chaganti RS
Important Adv Oncol; 1996; ():139-48. PubMed ID: 8791133
[No Abstract] [Full Text] [Related]
11. The BCL6 proto-oncogene: a leading role during germinal center development and lymphomagenesis.
Jardin F; Ruminy P; Bastard C; Tilly H
Pathol Biol (Paris); 2007 Feb; 55(1):73-83. PubMed ID: 16815642
[TBL] [Abstract][Full Text] [Related]
12. The BCL6 gene in B-cell lymphomas with 3q27 translocations is expressed mainly from the rearranged allele irrespective of the partner gene.
Lossos IS; Akasaka T; Martinez-Climent JA; Siebert R; Levy R
Leukemia; 2003 Jul; 17(7):1390-7. PubMed ID: 12835729
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of the LAZ3 (BCL6) proto-oncogene accompanies murine skeletal myogenesis.
Albagli-Curiel O; Dhordain P; Lantoine D; Auradé F; Quief S; Kerckaert JP; Montarras D; Pinset C
Differentiation; 1998 Nov; 64(1):33-44. PubMed ID: 9921651
[TBL] [Abstract][Full Text] [Related]
14. Analysis of LAZ3 (BCL-6) status in B-cell non-Hodgkin's lymphomas: results of rearrangement and gene expression studies and a mutational analysis of coding region sequences.
Otsuki T; Yano T; Clark HM; Bastard C; Kerckaert JP; Jaffe ES; Raffeld M
Blood; 1995 May; 85(10):2877-84. PubMed ID: 7742550
[TBL] [Abstract][Full Text] [Related]
15. Characterization of t(3;6)(q27;p21) breakpoints in B-cell non-Hodgkin's lymphoma and construction of the histone H4/BCL6 fusion gene, leading to altered expression of Bcl-6.
Kurata M; Maesako Y; Ueda C; Nishikori M; Akasaka T; Uchiyama T; Ohno H
Cancer Res; 2002 Nov; 62(21):6224-30. PubMed ID: 12414651
[TBL] [Abstract][Full Text] [Related]
16. ILA, the human 4-1BB homologue, is inducible in lymphoid and other cell lineages.
Schwarz H; Valbracht J; Tuckwell J; von Kempis J; Lotz M
Blood; 1995 Feb; 85(4):1043-52. PubMed ID: 7849293
[TBL] [Abstract][Full Text] [Related]
17. CD6 ligation modulates the Bcl-2/Bax ratio and protects chronic lymphocytic leukemia B cells from apoptosis induced by anti-IgM.
Osorio LM; De Santiago A; Aguilar-Santelises M; Mellstedt H; Jondal M
Blood; 1997 Apr; 89(8):2833-41. PubMed ID: 9108402
[TBL] [Abstract][Full Text] [Related]
18. A specific monoclonal antibody (PG-B6) detects expression of the BCL-6 protein in germinal center B cells.
Flenghi L; Ye BH; Fizzotti M; Bigerna B; Cattoretti G; Venturi S; Pacini R; Pileri S; Lo Coco F; Pescarmona E
Am J Pathol; 1995 Aug; 147(2):405-11. PubMed ID: 7639334
[TBL] [Abstract][Full Text] [Related]
19. Type I interferons directly down-regulate BCL-6 in primary and transformed germinal center B cells: differential regulation in B cell lines derived from endemic or sporadic Burkitt's lymphoma.
Salamon D; Adori M; He M; Bönelt P; Severinson E; Kis LL; Wu L; Ujvari D; Leveau B; Nagy N; Klein G; Klein E
Cytokine; 2012 Mar; 57(3):360-71. PubMed ID: 22204827
[TBL] [Abstract][Full Text] [Related]
20. NF-kappaB involvement in the activation of primary adult T-cell leukemia cells and its clinical implications.
Arima N; Matsushita K; Obata H; Ohtsubo H; Fujiwara H; Arimura K; Kukita T; Suruga Y; Wakamatsu S; Hidaka S; Tei C
Exp Hematol; 1999 Jul; 27(7):1168-75. PubMed ID: 10390192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
